These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21160069)

  • 1. Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes.
    Feng X; Scheinberg P; Wu CO; Samsel L; Nunez O; Prince C; Ganetzky RD; McCoy JP; Maciejewski JP; Young NS
    Haematologica; 2011 Apr; 96(4):602-6. PubMed ID: 21160069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome.
    Antin JH; Smith BR; Holmes W; Rosenthal DS
    Blood; 1988 Aug; 72(2):705-13. PubMed ID: 3042046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Cytokine-Based Diagnostic Program in Pediatric Aplastic Anemia and Hypocellular Refractory Cytopenia of Childhood.
    Elmahdi S; Hama A; Manabe A; Hasegawa D; Muramatsu H; Narita A; Nishio N; Ismael O; Kawashima N; Okuno Y; Xu Y; Wang X; Takahashi Y; Ito M; Kojima S
    Pediatr Blood Cancer; 2016 Apr; 63(4):652-8. PubMed ID: 26485171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous cytokine overproduction by peripheral blood mononuclear cells from patients with myelodysplastic syndromes and aplastic anemia.
    Koike M; Ishiyama T; Tomoyasu S; Tsuruoka N
    Leuk Res; 1995 Sep; 19(9):639-44. PubMed ID: 7564474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone Marrow Plasma Cytokine Signature Profiles in Severe Aplastic Anemia.
    Liu B; Shao Y; Liu Z; Liu C; Zhang T; Fu R
    Biomed Res Int; 2020; 2020():8789275. PubMed ID: 32190686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A plasma microRNA signature as a biomarker for acquired aplastic anemia.
    Hosokawa K; Kajigaya S; Feng X; Desierto MJ; Fernandez Ibanez MD; Rios O; Weinstein B; Scheinberg P; Townsley DM; Young NS
    Haematologica; 2017 Jan; 102(1):69-78. PubMed ID: 27658437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating S100A8 and S100A9 protein levels in plasma of patients with acquired aplastic anemia and myelodysplastic syndromes.
    Giudice V; Wu Z; Kajigaya S; Fernandez Ibanez MDP; Rios O; Cheung F; Ito S; Young NS
    Cytokine; 2019 Jan; 113():462-465. PubMed ID: 29958797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro study of erythropoiesis in patients with aplastic anemia and myelodysplastic syndromes: a possible tool for prospective determination of the clinical effectiveness of growth factors.
    Aoki A; Shibata A
    Hematol Pathol; 1992; 6(3):143-53. PubMed ID: 1429342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical study of GM-CSF in patients with aplastic anemia and myelodysplastic syndrome. (CSF39-300 Study Group)].
    Kitamura K; Asano S; Mizoguchi H; Takaku F
    Rinsho Ketsueki; 1993 Dec; 34(12):1540-9. PubMed ID: 8295327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine mRNA expression of bone marrow stromal cells from patients with aplastic anaemia and myelodysplastic syndrome.
    Hirayama Y; Kohgo Y; Matsunaga T; Ohi S; Sakamaki S; Niitsu Y
    Br J Haematol; 1993 Dec; 85(4):676-83. PubMed ID: 7522519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of long-term outcomes between children with aplastic anemia and refractory cytopenia of childhood who received immunosuppressive therapy with antithymocyte globulin and cyclosporine.
    Hama A; Takahashi Y; Muramatsu H; Ito M; Narita A; Kosaka Y; Tsuchida M; Kobayashi R; Ito E; Yabe H; Ohga S; Ohara A; Kojima S
    Haematologica; 2015 Nov; 100(11):1426-33. PubMed ID: 26273061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal evolution of aplastic anaemia to myelodysplasia/acute myeloid leukaemia and paroxysmal nocturnal haemoglobinuria.
    Tooze JA; Marsh JC; Gordon-Smith EC
    Leuk Lymphoma; 1999 Apr; 33(3-4):231-41. PubMed ID: 10221503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased levels of soluble tumor necrosis factor receptors in patients with aplastic anemia and myelodysplastic syndrome.
    Shinohara K; Muraki K; Ota I; Nawata R; Oeda E; Takahashi T
    Am J Hematol; 2000 Dec; 65(4):326-7. PubMed ID: 11074567
    [No Abstract]   [Full Text] [Related]  

  • 14. Flow cytometric evaluation of circulating CD34+ cell counts and apoptotic rate in children with acquired aplastic anemia and myelodysplasia.
    Timeus F; Crescenzio N; Doria A; Foglia L; Linari A; Giaccone M; Pastore G; di Montezemolo LC; Ramenghi U; Saracco P
    Exp Hematol; 2005 May; 33(5):597-604. PubMed ID: 15850838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma lactoferrin content in neutropenic patients: effects of treatment with recombinant granulocyte-macrophage colony-stimulating factor.
    Bezwoda WR; Dajee D
    Mol Biother; 1992 Jun; 4(2):103-6. PubMed ID: 1515094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of dysplastic changes in acquired aplastic anemia: A systematic study of bone marrow biopsies in children and adults.
    Marchesi RF; Velloso EDRP; Garanito MP; Leal AM; Siqueira SAC; Azevedo Neto RS; Rocha V; Zerbini MCN
    Ann Diagn Pathol; 2020 Apr; 45():151459. PubMed ID: 32000075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of recombinant human granulocyte-macrophage colony-stimulating factor in myelodysplastic syndrome and aplastic anemia.
    Takahashi M; Yoshida Y; Kaku K; Masaoka T; Moriyama Y; Nakanishi S; Kaneko T; Shibata A; Miwa S
    Acta Haematol; 1993; 89(4):189-94. PubMed ID: 8212999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent elevated bone marrow plasma levels of thrombopoietin in patients with aplastic anemia.
    Zhang J; Wu Q; Zheng Y
    Cytokine; 2016 Sep; 85():11-3. PubMed ID: 27269179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of aplastic anaemia with granulocyte-colony stimulating factor and risk of malignancy. Italian Aplastic Anaemia Study Group.
    Locasciulli A; Arcese W; Locatelli F; Di Bona E; Bacigalupo A;
    Lancet; 2001 Jan; 357(9249):43-4. PubMed ID: 11197365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of the Fas ligand on peripheral blood mononuclear cells and undetectable levels of soluble Fas ligand in the serum of patients with aplastic anemia and myelodysplastic syndrome.
    Shinohara K; Takahahi T; Nawata R; Oeda E
    Am J Hematol; 1999 Oct; 62(2):124-5. PubMed ID: 10509009
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.